Music: A Safe Alternative to Psychiatric Drugs for Dementia Patients - Jordan News
(Source: Lenta.ru)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Jordan News
19-07-2025
- Jordan News
Music: A Safe Alternative to Psychiatric Drugs for Dementia Patients - Jordan News
Music: A Safe Alternative to Psychiatric Drugs for Dementia Patients A recent study has shown that listening to music can improve the mental and emotional well-being of dementia patients receiving care in hospitals and health centers. اضافة اعلان According to Frontiers in Psychiatry, researchers from Anglia Ruskin University in the UK, in collaboration with the Cambridgeshire and Peterborough NHS Foundation Trust, conducted a study under the MELODIC program to assess the impact of music on the psychological and cognitive state of hospitalized dementia patients. As part of the study, a full-time music therapist worked in two dementia wards, where individualized music plans were created for each patient. These plans included singing sessions, music listening, and playing musical instruments. The results revealed a modest improvement in patients' quality of life, along with a reduction in stress and confusion symptoms—without any reported adverse side effects from the therapy. According to the study's authors, music therapy could serve as a safe alternative to psychiatric medications, which are commonly used to reduce anxiety and aggression in dementia patients. They also suggested that this model could be expanded to more healthcare centers to improve patient outcomes and ease the burden on healthcare staff. Other studies have indicated that listening to music may also help reduce pain in patients with certain conditions, serving as a distraction and a way to alleviate discomfort from injuries. (Source:
Jordan News
03-07-2025
- Jordan News
A Diet That Protects Against One of the Most Dangerous Liver Diseases - Jordan News
A Diet That Protects Against One of the Most Dangerous Liver Diseases A recent Spanish study has revealed that following a specific diet can significantly reduce the risk of developing Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — one of the most prevalent liver diseases. اضافة اعلان According to the journal Nutrients, Spanish researchers investigating the causes of MASLD and the impact of dietary patterns found that certain diets — particularly the Mediterranean diet — effectively lower the risk of this condition. In their research, scientists from Rovira i Virgili University in Spain conducted a comprehensive analysis of 13 scientific studies involving 926 participants to evaluate the effects of various diets on MASLD. The findings showed that the Mediterranean diet, which emphasizes vegetables, fish, whole grains, and olive oil, achieved the best results in reducing the risk of fat accumulation in the liver. The study also demonstrated that the Mediterranean diet helps to: Lower markers of MASLD Improve blood sugar control Reduce inflammation triggers in the body Researchers also observed a positive effect of intermittent fasting on patient outcomes. However, they emphasized the need for long-term studies to confirm the sustainability of these benefits on liver function and to identify optimal dietary protocols. The research team stressed that MASLD is influenced by multiple risk factors, with nutrition playing a central role. Their findings offer hope for developing effective dietary strategies to prevent liver diseases associated with obesity. Source:
Jordan News
03-07-2025
- Jordan News
China Develops New Anti-Obesity Drugs with Added Benefits for Heart, Liver, and Diabetes - Jordan News
China Develops New Anti-Obesity Drugs with Added Benefits for Heart, Liver, and Diabetes According to Nature magazine, Chinese scientists are currently developing a new generation of anti-obesity medications that not only promote weight loss but also improve heart and liver health, while aiding in the management of type 2 diabetes. اضافة اعلان In a recent study, researchers tested a new drug called Ecnoglutide, which demonstrated significant effects: individuals with obesity lost an average of 13.8 kilograms over a period of 48 weeks, and reduced more than 5% of their body mass. Scientists explained that Ecnoglutide mimics the action of the GLP-1 hormone, which regulates appetite and blood sugar levels. Unlike existing medications such as Semaglutide, the new drug targets different molecular pathways, which may not only enhance weight loss but also help maintain the results after treatment ends. Clinical trials also showed improvements in indicators linked to cardiovascular disease risk and fatty liver disease. In parallel, Chinese pharmaceutical companies are testing new formulations of weight-loss medications that offer additional benefits for the heart and liver. These include bi-weekly injections and oral medications, with some drugs combining the effects of three hormones to target fat and sugar metabolism, as well as liver function. One such medication is UBT251, which has been approved for international marketing by pharmaceutical giant Novo Nordisk. Researchers emphasize that the development of these drugs is no coincidence. Obesity and diabetes are among the most pressing health issues in China and India, and these new medications may pave the way for targeted treatments that take into account the unique metabolic profiles of Asian populations and the comorbidities associated with obesity in the region. —
